Edge Pharma, LLC is recalling 5,850 units of Betadine (Povidone-Iodine) 5% sterile ophthalmic solution due to a defect in the syringe container. The solution, which is used topically for eye procedures, was found to have contents migrating past the plunger seal, which can compromise the product's sterility. This recall affects single-use syringes from Lot 02-2021-16 distributed nationwide in the US. Consumers should not use the affected product and should contact their healthcare provider or pharmacist immediately.
The defect allows the liquid medication to move past the plunger's seal, which may introduce contaminants into the syringe. This creates a lack of assurance of sterility, potentially leading to serious eye infections if used during ophthalmic procedures.
Healthcare provider consultation and pharmacy return.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.